CML Case Characteristics | DIAGNOSIS PRE-TKI (before February 1, 2002) | DIAGNOSIS Post-TKI (after February 1, 2002) | ||||
---|---|---|---|---|---|---|
dead on August 1, 2002 (Pre-TKI cases) | alive on August 1, 2002 (Prevalent cases) | (Incident cases) | ||||
SEX | N | % | N | % | N | % |
 M | 48 | 64.0 | 42 | 57.5 | 117 | 56.0 |
 F | 27 | 36.0 | 31 | 42.4 | 92 | 44.0 |
AGE AT DIAGNOSIS | ||||||
  < 65 yrs | 17 | 22.7 | 40 | 54.8 | 117 | 56.0 |
 65–74 yrs | 23 | 30.7 | 22 | 30.1 | 46 | 22.0 |
  > 74 yrs | 35 | 46.7 | 11 | 15.1 | 46 | 22.0 |
RESIDENCY | ||||||
 non-mountainous area | 64 | 85.3 | 65 | 89.0 | 193 | 92.3 |
 mountainous area | 11 | 14.7 | 8 | 11.0 | 16 | 7.7 |
TOTAL | 75 | 100 | 73 | 100 | 209 | 100 |
SURVIVAL | Diagnosis before February 1, 2002 | Diagnosis after February 1, 2002 | ||||
Relative Survival % (95% CI) | Disease-specific Survival % (95% CI) | Relative Survival % (95% CI) | Disease-specific Survival % (95% CI) | |||
 1 year | 81.43% (73.55–87.47) | 83.36% (76.21–88.53) | 90.54% (85.31–94.22) | 91.28% (86.52–94.42) | ||
 3 years | 56.55% (47.34–65.06) | 60.38% (51.69–68.00) | 80.95% (74.26–86.40) | 84.52% (78.70–88.86) | ||
 5 years | 40.82% (31.96–49.75) | 47.26% (38.49–55.53) | 77.01% (69.65–83.25) | 80.85% (74.49–85.78) | ||
 10 years | 34.50% (25.76–43.76) | 38.41% (29.90–46.85) | 70.85% (61.55–79.08) | 76.97% (69.52–82.82) | ||
5-yr SURVIVAL by AGE AT DIAGNOSIS | Diagnosis before February 1, 2002 | Diagnosis after February 1, 2002 | ||||
Relative Survival % (95% CI) | Disease-specific Survival % (95% CI) | Relative Survival % (95% CI) | Disease-specific Survival % (95% CI) | |||
  < 65 yrs | 66.34% (51.84–77.60) | 69.08% (55.03–79.52) | 92.49% (85.31–96.59) | 94.63% (88.41–97.55) | ||
 65–74 yrs | 39.31% (23.83–55.31) | 46.77% (30.83–61.22) | 67.59% (50.58–81.06) | 69.01% (52.50–80.78) | ||
  > 74 yrs | 3.49% (0.28–15.97) | 8.05% (0.81–26.72) | 40.27% (22.01–60.78) | 51.21% (32.44–67.17) |